Global Endometriosis Drugs Market Size, Status and Forecast 2020-2026

Global Endometriosis Drugs Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Endometriosis Drugs Revenue
1.4 Market by Type
1.4.1 Global Endometriosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hormonal Therapy
1.4.3 Add-back Medication
1.4.4 Progestogens
1.4.5 Chinese Herbs
1.5 Market by Application
1.5.1 Global Endometriosis Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Endometriosis Drugs Market Perspective (2015-2026)
2.2 Global Endometriosis Drugs Growth Trends by Regions
2.2.1 Endometriosis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Endometriosis Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Endometriosis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Endometriosis Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Endometriosis Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Drugs Players by Market Size
3.1.1 Global Top Endometriosis Drugs Players by Revenue (2015-2020)
3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Endometriosis Drugs Market Concentration Ratio
3.2.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2019
3.3 Endometriosis Drugs Key Players Head office and Area Served
3.4 Key Players Endometriosis Drugs Product Solution and Service
3.5 Date of Enter into Endometriosis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Endometriosis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Endometriosis Drugs Market Size by Application (2015-2020)
5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Endometriosis Drugs Market Size (2015-2020)
6.2 Endometriosis Drugs Key Players in North America (2019-2020)
6.3 North America Endometriosis Drugs Market Size by Type (2015-2020)
6.4 North America Endometriosis Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Endometriosis Drugs Market Size (2015-2020)
7.2 Endometriosis Drugs Key Players in Europe (2019-2020)
7.3 Europe Endometriosis Drugs Market Size by Type (2015-2020)
7.4 Europe Endometriosis Drugs Market Size by Application (2015-2020)
8 China
8.1 China Endometriosis Drugs Market Size (2015-2020)
8.2 Endometriosis Drugs Key Players in China (2019-2020)
8.3 China Endometriosis Drugs Market Size by Type (2015-2020)
8.4 China Endometriosis Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Endometriosis Drugs Market Size (2015-2020)
9.2 Endometriosis Drugs Key Players in Japan (2019-2020)
9.3 Japan Endometriosis Drugs Market Size by Type (2015-2020)
9.4 Japan Endometriosis Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Endometriosis Drugs Market Size (2015-2020)
10.2 Endometriosis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Endometriosis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Endometriosis Drugs Market Size by Application (2015-2020)
11 India
11.1 India Endometriosis Drugs Market Size (2015-2020)
11.2 Endometriosis Drugs Key Players in India (2019-2020)
11.3 India Endometriosis Drugs Market Size by Type (2015-2020)
11.4 India Endometriosis Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Endometriosis Drugs Market Size (2015-2020)
12.2 Endometriosis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Endometriosis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Endometriosis Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Endometriosis Drugs Introduction
13.1.4 AbbVie Revenue in Endometriosis Drugs Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Astellas Pharma
13.2.1 Astellas Pharma Company Details
13.2.2 Astellas Pharma Business Overview
13.2.3 Astellas Pharma Endometriosis Drugs Introduction
13.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2015-2020)
13.2.5 Astellas Pharma Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Endometriosis Drugs Introduction
13.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Debiopharm Group
13.4.1 Debiopharm Group Company Details
13.4.2 Debiopharm Group Business Overview
13.4.3 Debiopharm Group Endometriosis Drugs Introduction
13.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2015-2020)
13.4.5 Debiopharm Group Recent Development
13.5 Evotec AG
13.5.1 Evotec AG Company Details
13.5.2 Evotec AG Business Overview
13.5.3 Evotec AG Endometriosis Drugs Introduction
13.5.4 Evotec AG Revenue in Endometriosis Drugs Business (2015-2020)
13.5.5 Evotec AG Recent Development
13.6 Kissei Pharmaceutical
13.6.1 Kissei Pharmaceutical Company Details
13.6.2 Kissei Pharmaceutical Business Overview
13.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction
13.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2015-2020)
13.6.5 Kissei Pharmaceutical Recent Development
13.7 Neurocrine Biosciences
13.7.1 Neurocrine Biosciences Company Details
13.7.2 Neurocrine Biosciences Business Overview
13.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction
13.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2015-2020)
13.7.5 Neurocrine Biosciences Recent Development
13.8 ObsEva
13.8.1 ObsEva Company Details
13.8.2 ObsEva Business Overview
13.8.3 ObsEva Endometriosis Drugs Introduction
13.8.4 ObsEva Revenue in Endometriosis Drugs Business (2015-2020)
13.8.5 ObsEva Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview
13.9.3 Pfizer Endometriosis Drugs Introduction
13.9.4 Pfizer Revenue in Endometriosis Drugs Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Repros Therapeutics
13.10.1 Repros Therapeutics Company Details
13.10.2 Repros Therapeutics Business Overview
13.10.3 Repros Therapeutics Endometriosis Drugs Introduction
13.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2015-2020)
13.10.5 Repros Therapeutics Recent Development
13.11 Roivant Sciences GmbH
10.11.1 Roivant Sciences GmbH Company Details
10.11.2 Roivant Sciences GmbH Business Overview
10.11.3 Roivant Sciences GmbH Endometriosis Drugs Introduction
10.11.4 Roivant Sciences GmbH Revenue in Endometriosis Drugs Business (2015-2020)
10.11.5 Roivant Sciences GmbH Recent Development
13.12 Takeda Pharmaceutical Company Limited
10.12.1 Takeda Pharmaceutical Company Limited Company Details
10.12.2 Takeda Pharmaceutical Company Limited Business Overview
10.12.3 Takeda Pharmaceutical Company Limited Endometriosis Drugs Introduction
10.12.4 Takeda Pharmaceutical Company Limited Revenue in Endometriosis Drugs Business (2015-2020)
10.12.5 Takeda Pharmaceutical Company Limited Recent Development
13.13 ValiRx
10.13.1 ValiRx Company Details
10.13.2 ValiRx Business Overview
10.13.3 ValiRx Endometriosis Drugs Introduction
10.13.4 ValiRx Revenue in Endometriosis Drugs Business (2015-2020)
10.13.5 ValiRx Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Endometriosis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Endometriosis Drugs Revenue
Table 3. Ranking of Global Top Endometriosis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Add-back Medication
Table 7. Key Players of Progestogens
Table 8. Key Players of Chinese Herbs
Table 9. Global Endometriosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Endometriosis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Endometriosis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Endometriosis Drugs Market Share by Regions (2015-2020)
Table 13. Global Endometriosis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Endometriosis Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Endometriosis Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Endometriosis Drugs Players
Table 20. Global Endometriosis Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Endometriosis Drugs Market Share by Players (2015-2020)
Table 22. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Drugs as of 2019)
Table 23. Global Endometriosis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Endometriosis Drugs Product Solution and Service
Table 26. Date of Enter into Endometriosis Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Endometriosis Drugs Market Size Share by Type (2015-2020)
Table 30. Global Endometriosis Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Endometriosis Drugs Market Size Share by Application (2015-2020)
Table 32. Global Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Endometriosis Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Endometriosis Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Endometriosis Drugs Market Share (2019-2020)
Table 36. North America Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Endometriosis Drugs Market Share by Type (2015-2020)
Table 38. North America Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Endometriosis Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Endometriosis Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Endometriosis Drugs Market Share (2019-2020)
Table 42. Europe Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Endometriosis Drugs Market Share by Type (2015-2020)
Table 44. Europe Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Endometriosis Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Endometriosis Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Endometriosis Drugs Market Share (2019-2020)
Table 48. China Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Endometriosis Drugs Market Share by Type (2015-2020)
Table 50. China Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Endometriosis Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Endometriosis Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Endometriosis Drugs Market Share (2019-2020)
Table 54. Japan Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Endometriosis Drugs Market Share by Type (2015-2020)
Table 56. Japan Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Endometriosis Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Endometriosis Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Endometriosis Drugs Market Share (2019-2020)
Table 60. Southeast Asia Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Endometriosis Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Endometriosis Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Endometriosis Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Endometriosis Drugs Market Share (2019-2020)
Table 66. India Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Endometriosis Drugs Market Share by Type (2015-2020)
Table 68. India Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Endometriosis Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Endometriosis Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Endometriosis Drugs Market Share (2019-2020)
Table 72. Central & South America Endometriosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Endometriosis Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Endometriosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Endometriosis Drugs Market Share by Application (2015-2020)
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Product
Table 79. AbbVie Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 80. AbbVie Recent Development
Table 81. Astellas Pharma Company Details
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Product
Table 84. Astellas Pharma Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 85. Astellas Pharma Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. Debiopharm Group Company Details
Table 92. Debiopharm Group Business Overview
Table 93. Debiopharm Group Product
Table 94. Debiopharm Group Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 95. Debiopharm Group Recent Development
Table 96. Evotec AG Company Details
Table 97. Evotec AG Business Overview
Table 98. Evotec AG Product
Table 99. Evotec AG Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 100. Evotec AG Recent Development
Table 101. Kissei Pharmaceutical Company Details
Table 102. Kissei Pharmaceutical Business Overview
Table 103. Kissei Pharmaceutical Product
Table 104. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 105. Kissei Pharmaceutical Recent Development
Table 106. Neurocrine Biosciences Company Details
Table 107. Neurocrine Biosciences Business Overview
Table 108. Neurocrine Biosciences Product
Table 109. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 110. Neurocrine Biosciences Recent Development
Table 111. ObsEva Business Overview
Table 112. ObsEva Product
Table 113. ObsEva Company Details
Table 114. ObsEva Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 115. ObsEva Recent Development
Table 116. Pfizer Company Details
Table 117. Pfizer Business Overview
Table 118. Pfizer Product
Table 119. Pfizer Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 120. Pfizer Recent Development
Table 121. Repros Therapeutics Company Details
Table 122. Repros Therapeutics Business Overview
Table 123. Repros Therapeutics Product
Table 124. Repros Therapeutics Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 125. Repros Therapeutics Recent Development
Table 126. Roivant Sciences GmbH Company Details
Table 127. Roivant Sciences GmbH Business Overview
Table 128. Roivant Sciences GmbH Product
Table 129. Roivant Sciences GmbH Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 130. Roivant Sciences GmbH Recent Development
Table 131. Takeda Pharmaceutical Company Limited Company Details
Table 132. Takeda Pharmaceutical Company Limited Business Overview
Table 133. Takeda Pharmaceutical Company Limited Product
Table 134. Takeda Pharmaceutical Company Limited Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 135. Takeda Pharmaceutical Company Limited Recent Development
Table 136. ValiRx Company Details
Table 137. ValiRx Business Overview
Table 138. ValiRx Product
Table 139. ValiRx Revenue in Endometriosis Drugs Business (2015-2020) (Million US$)
Table 140. ValiRx Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Hormonal Therapy Features
Figure 3. Add-back Medication Features
Figure 4. Progestogens Features
Figure 5. Chinese Herbs Features
Figure 6. Global Endometriosis Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Endometriosis Drugs Report Years Considered
Figure 11. Global Endometriosis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Endometriosis Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Endometriosis Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Endometriosis Drugs Market Share by Players in 2019
Figure 16. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2019
Figure 18. North America Endometriosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Endometriosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Endometriosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Endometriosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Endometriosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Endometriosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs